Health ❯Medicine ❯Pharmacology ❯Diabetes

Semaglutide

GLP-1 Weight-Loss Injections Show Hormonal and Neuroprotective Benefits

Mid-July observational data reveal testosterone restoration alongside reduced dementia risk, prompting experts to demand randomized trials.

Semaglutide Demonstrates Dual Promise in Type 1 Diabetes and Dementia Prevention

FDA Approves Ozempic for Chronic Kidney Disease in Type 2 Diabetes Patients

Ozempic May Lower Alzheimer's Risk in Type 2 Diabetics, Study Finds